Center-Authored Papers

Filters: Author is Eberhart, Charles G  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
2008
Hatton BA, Villavicencio EH, Tsuchiya KD, Pritchard JI, Ditzler S, Pullar B, Hansen S, Knoblaugh SE, Lee D, Eberhart CG et al..  2008.  The Smo/Smo model: hedgehog-induced medulloblastoma with 90% incidence and leptomeningeal spread.. Cancer research. 68(6):1768-76. Abstract
2011
Cho Y-J, Tsherniak A, Tamayo P, Santagata S, Ligon A, Greulich H, Berhoukim R, Amani V, Goumnerova L, Eberhart CG et al..  2011.  Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 29(11):1424-30. Abstract
2013
Aref D, Moffatt CJ, Agnihotri S, Ramaswamy V, Dubuc AM, Northcott PA, Taylor MD, Perry A, Olson JM, Eberhart CG et al..  2013.  Canonical TGF-β Pathway Activity Is a Predictor of SHH-Driven Medulloblastoma Survival and Delineates Putative Precursors in Cerebellar Development.. Brain pathology (Zurich, Switzerland). 23(2):178-91. Abstract
2014
Shih DJH, Northcott PA, Remke M, Korshunov A, Ramaswamy V, Kool M, Luu B, Yao Y, Wang X, Dubuc AM et al..  2014.  Cytogenetic Prognostication Within Medulloblastoma Subgroups.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 32(9):886-96. Abstract
Algorithms
Cho Y-J, Tsherniak A, Tamayo P, Santagata S, Ligon A, Greulich H, Berhoukim R, Amani V, Goumnerova L, Eberhart CG et al..  2011.  Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 29(11):1424-30. Abstract
Animals
Hatton BA, Villavicencio EH, Tsuchiya KD, Pritchard JI, Ditzler S, Pullar B, Hansen S, Knoblaugh SE, Lee D, Eberhart CG et al..  2008.  The Smo/Smo model: hedgehog-induced medulloblastoma with 90% incidence and leptomeningeal spread.. Cancer research. 68(6):1768-76. Abstract
August 2012
Northcott PA, Shih DJH, Peacock J, Garzia L, Morrissy SA, Zichner T, Stütz AM, Korshunov A, Reimand J, Schumacher SE et al..  2012.  Subgroup-specific structural variation across 1,000 medulloblastoma genomes.. Nature. 488(7409):49-56. Abstract
Bioinformatics Core Facility
Wu N, Jia D, Bates B, Basom R, Eberhart CG, MacPherson D.  2017.  A mouse model of MYCN-driven retinoblastoma reveals MYCN-independent tumor reemergence.. The Journal of clinical investigation. 127(3):888-898. Abstract
Carrier Proteins
Northcott PA, Shih DJH, Peacock J, Garzia L, Morrissy SA, Zichner T, Stütz AM, Korshunov A, Reimand J, Schumacher SE et al..  2012.  Subgroup-specific structural variation across 1,000 medulloblastoma genomes.. Nature. 488(7409):49-56. Abstract
Cell Processing Core Facility
Shih DJH, Northcott PA, Remke M, Korshunov A, Ramaswamy V, Kool M, Luu B, Yao Y, Wang X, Dubuc AM et al..  2014.  Cytogenetic Prognostication Within Medulloblastoma Subgroups.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 32(9):886-96. Abstract
Center-Authored Paper
Hatton BA, Villavicencio EH, Tsuchiya KD, Pritchard JI, Ditzler S, Pullar B, Hansen S, Knoblaugh SE, Lee D, Eberhart CG et al..  2008.  The Smo/Smo model: hedgehog-induced medulloblastoma with 90% incidence and leptomeningeal spread.. Cancer research. 68(6):1768-76. Abstract
Aref D, Moffatt CJ, Agnihotri S, Ramaswamy V, Dubuc AM, Northcott PA, Taylor MD, Perry A, Olson JM, Eberhart CG et al..  2013.  Canonical TGF-β Pathway Activity Is a Predictor of SHH-Driven Medulloblastoma Survival and Delineates Putative Precursors in Cerebellar Development.. Brain pathology (Zurich, Switzerland). 23(2):178-91. Abstract
Shih DJH, Northcott PA, Remke M, Korshunov A, Ramaswamy V, Kool M, Luu B, Yao Y, Wang X, Dubuc AM et al..  2014.  Cytogenetic Prognostication Within Medulloblastoma Subgroups.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 32(9):886-96. Abstract
Cerebellar Neoplasms
Cho Y-J, Tsherniak A, Tamayo P, Santagata S, Ligon A, Greulich H, Berhoukim R, Amani V, Goumnerova L, Eberhart CG et al..  2011.  Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 29(11):1424-30. Abstract
Northcott PA, Shih DJH, Peacock J, Garzia L, Morrissy SA, Zichner T, Stütz AM, Korshunov A, Reimand J, Schumacher SE et al..  2012.  Subgroup-specific structural variation across 1,000 medulloblastoma genomes.. Nature. 488(7409):49-56. Abstract
Hatton BA, Villavicencio EH, Tsuchiya KD, Pritchard JI, Ditzler S, Pullar B, Hansen S, Knoblaugh SE, Lee D, Eberhart CG et al..  2008.  The Smo/Smo model: hedgehog-induced medulloblastoma with 90% incidence and leptomeningeal spread.. Cancer research. 68(6):1768-76. Abstract
Child
Northcott PA, Shih DJH, Peacock J, Garzia L, Morrissy SA, Zichner T, Stütz AM, Korshunov A, Reimand J, Schumacher SE et al..  2012.  Subgroup-specific structural variation across 1,000 medulloblastoma genomes.. Nature. 488(7409):49-56. Abstract
Cho Y-J, Tsherniak A, Tamayo P, Santagata S, Ligon A, Greulich H, Berhoukim R, Amani V, Goumnerova L, Eberhart CG et al..  2011.  Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 29(11):1424-30. Abstract
Clinical Research Division
Cho Y-J, Tsherniak A, Tamayo P, Santagata S, Ligon A, Greulich H, Berhoukim R, Amani V, Goumnerova L, Eberhart CG et al..  2011.  Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 29(11):1424-30. Abstract
Northcott PA, Shih DJH, Peacock J, Garzia L, Morrissy SA, Zichner T, Stütz AM, Korshunov A, Reimand J, Schumacher SE et al..  2012.  Subgroup-specific structural variation across 1,000 medulloblastoma genomes.. Nature. 488(7409):49-56. Abstract
Shih DJH, Northcott PA, Remke M, Korshunov A, Ramaswamy V, Kool M, Luu B, Yao Y, Wang X, Dubuc AM et al..  2014.  Cytogenetic Prognostication Within Medulloblastoma Subgroups.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 32(9):886-96. Abstract
Hatton BA, Villavicencio EH, Tsuchiya KD, Pritchard JI, Ditzler S, Pullar B, Hansen S, Knoblaugh SE, Lee D, Eberhart CG et al..  2008.  The Smo/Smo model: hedgehog-induced medulloblastoma with 90% incidence and leptomeningeal spread.. Cancer research. 68(6):1768-76. Abstract
Aref D, Moffatt CJ, Agnihotri S, Ramaswamy V, Dubuc AM, Northcott PA, Taylor MD, Perry A, Olson JM, Eberhart CG et al..  2013.  Canonical TGF-β Pathway Activity Is a Predictor of SHH-Driven Medulloblastoma Survival and Delineates Putative Precursors in Cerebellar Development.. Brain pathology (Zurich, Switzerland). 23(2):178-91. Abstract
Comp Med Small Animal
Shih DJH, Northcott PA, Remke M, Korshunov A, Ramaswamy V, Kool M, Luu B, Yao Y, Wang X, Dubuc AM et al..  2014.  Cytogenetic Prognostication Within Medulloblastoma Subgroups.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 32(9):886-96. Abstract
Comparative Medicine Core Facility
Shih DJH, Northcott PA, Remke M, Korshunov A, Ramaswamy V, Kool M, Luu B, Yao Y, Wang X, Dubuc AM et al..  2014.  Cytogenetic Prognostication Within Medulloblastoma Subgroups.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 32(9):886-96. Abstract